DK1343789T3 - Tricykliske derivater af indol med antiangiogen aktivitet - Google Patents

Tricykliske derivater af indol med antiangiogen aktivitet

Info

Publication number
DK1343789T3
DK1343789T3 DK01983768T DK01983768T DK1343789T3 DK 1343789 T3 DK1343789 T3 DK 1343789T3 DK 01983768 T DK01983768 T DK 01983768T DK 01983768 T DK01983768 T DK 01983768T DK 1343789 T3 DK1343789 T3 DK 1343789T3
Authority
DK
Denmark
Prior art keywords
indole
antiangiogenic activity
tricyclic derivatives
tricyclic
derivatives
Prior art date
Application number
DK01983768T
Other languages
Danish (da)
English (en)
Inventor
Giuseppe Giannini
Mauro Marzi
Maria Ornella Tinti
Claudio Pisano
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK1343789T3 publication Critical patent/DK1343789T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK01983768T 2000-11-03 2001-10-16 Tricykliske derivater af indol med antiangiogen aktivitet DK1343789T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000570A IT1317926B1 (it) 2000-11-03 2000-11-03 Derivati triciclici dell'indolo ad attivita' antiangiogenica.

Publications (1)

Publication Number Publication Date
DK1343789T3 true DK1343789T3 (da) 2005-12-27

Family

ID=11454976

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01983768T DK1343789T3 (da) 2000-11-03 2001-10-16 Tricykliske derivater af indol med antiangiogen aktivitet

Country Status (20)

Country Link
US (2) US6887892B2 (ja)
EP (1) EP1343789B1 (ja)
JP (1) JP2004513130A (ja)
KR (1) KR20030042030A (ja)
CN (1) CN1247589C (ja)
AT (1) ATE302780T1 (ja)
AU (1) AU1518602A (ja)
BR (1) BR0115119A (ja)
CA (1) CA2427568A1 (ja)
CZ (1) CZ297299B6 (ja)
DE (1) DE60112966T2 (ja)
DK (1) DK1343789T3 (ja)
ES (1) ES2247182T3 (ja)
HK (1) HK1061244A1 (ja)
HU (1) HUP0400546A3 (ja)
IT (1) IT1317926B1 (ja)
MX (1) MXPA03003798A (ja)
PL (1) PL364908A1 (ja)
SK (1) SK5342003A3 (ja)
WO (1) WO2002036597A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6849656B1 (en) 1999-09-17 2005-02-01 Baylor University Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents
US7528165B2 (en) 2001-12-13 2009-05-05 National Health Research Institutes Indole compounds
US7632955B2 (en) 2001-12-13 2009-12-15 National Health Research Institutes Indole compounds
US6800655B2 (en) 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
US7456289B2 (en) 2004-12-31 2008-11-25 National Health Research Institutes Anti-tumor compounds
AR052674A1 (es) * 2005-02-17 2007-03-28 Wyeth Corp Derivados de indol, benzotiofeno, benzofurano e indeno cicloalquilcondensados
EP1852429B1 (de) * 2006-04-25 2010-09-15 Merck Patent GmbH Hexahydro-dibenzofuranderivate
FR2928645A1 (fr) 2008-03-14 2009-09-18 Sanofi Aventis Sa Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
WO2014041125A1 (en) * 2012-09-13 2014-03-20 Baden-Württemberg Stiftung Gmbh Specific inhibitors of protein p21 as therapeutic agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5100891A (en) 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
US5350762A (en) * 1993-03-08 1994-09-27 Hoechst-Roussel Pharmaceuticals Incorporated Tetrahydrocyclopent[B]indole methanamines and related compounds

Also Published As

Publication number Publication date
SK5342003A3 (en) 2003-10-07
CA2427568A1 (en) 2002-05-10
ITRM20000570A0 (it) 2000-11-03
HK1061244A1 (en) 2004-09-10
ATE302780T1 (de) 2005-09-15
US6887892B2 (en) 2005-05-03
EP1343789B1 (en) 2005-08-24
EP1343789A1 (en) 2003-09-17
JP2004513130A (ja) 2004-04-30
KR20030042030A (ko) 2003-05-27
CZ297299B6 (cs) 2006-11-15
DE60112966T2 (de) 2006-05-24
IT1317926B1 (it) 2003-07-15
CZ20031042A3 (cs) 2003-10-15
HUP0400546A3 (en) 2007-08-28
PL364908A1 (en) 2004-12-27
ES2247182T3 (es) 2006-03-01
WO2002036597A1 (en) 2002-05-10
HUP0400546A2 (hu) 2004-06-28
ITRM20000570A1 (it) 2002-05-03
US20050124647A1 (en) 2005-06-09
DE60112966D1 (de) 2005-09-29
CN1471535A (zh) 2004-01-28
MXPA03003798A (es) 2004-04-20
US20040034052A1 (en) 2004-02-19
AU1518602A (en) 2002-05-15
CN1247589C (zh) 2006-03-29
BR0115119A (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
TR200003206T2 (tr) İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.
TR200003514T2 (tr) Pirol ikame edilmiş 2-indolinon protein kinaz inhibitörleri
EA200300793A1 (ru) Производные 3-(4-амидопиррол-2-илметилиден)-2-индолинона в качестве ингибиторов протеинкиназ
DE69425637T2 (de) Aryliden-und heteroaryliden-oxindol derivate als tyrosin kinase inhibitoren
ATE348616T1 (de) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
ATE353217T1 (de) 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren
DE69929463D1 (de) Polyhydroxylierte heterocyclische derivate als antikoagulanten
ATE302775T1 (de) Carbolinderivate
ATE316527T1 (de) Substituierte indolinone als tyrosinkinase inhibitoren
MXPA04006271A (es) Derivados de indolinona utiles como inhibidores de la proteina cinasa.
ATE346067T1 (de) Carbolinderivate
DK1343789T3 (da) Tricykliske derivater af indol med antiangiogen aktivitet
DE60115656D1 (de) Verwendung von 3-substituierten oxidinolderivaten als kcnq kaliumkanalmodulatoren
NO20022976L (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
BR0109512A (pt) Imidazopiridinas tricìclicas
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE259813T1 (de) Triazolopyrimidinderivate
ATE337320T1 (de) Indolderivate als pde5-inhibitoren
TR200201689T2 (tr) Yeni indol türevleri
YU83100A (sh) Fkbp inhibitori
DE69906101D1 (de) 3-bicycloindole als liganden des 5-ht 1d rezeptors
ATE435200T1 (de) Guanidinophenylalanin-verbindungen als urokinase- inhibitoren
ATE243698T1 (de) 1,2-dihydro-1-oxo-pyrazino(1,2-)indolederivate
ATE350381T1 (de) Indolderivate und deren verwendung als 5-ht liganden
EA200501669A1 (ru) Замещенные производные индолина и индола